| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1340 | 2022 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 960 | 2017 |
| Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ... Jama 313 (19), 1939-1950, 2015 | 660 | 2015 |
| Clinical validity of the ‘mini-mental state’for Spanish speaking communities R Blesa, M Pujol, M Aguilar, P Santacruz, I Bertran-Serra, G Hernández, ... Neuropsychologia 39 (11), 1150-1157, 2001 | 565 | 2001 |
| Spanish Multicenter Normative Studies (NEURONORMA Project): norms for verbal span, visuospatial span, letter and number sequencing, trail making test, and symbol digit … J Peña-Casanova, S Quiñones-Úbeda, M Quintana-Aparicio, M Aguilar, ... Archives of Clinical Neuropsychology 24 (4), 321-341, 2009 | 546* | 2009 |
| sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ... EMBO molecular medicine 8 (5), 466-476, 2016 | 494 | 2016 |
| Frontotemporal dementia and its subtypes: a genome-wide association study R Ferrari, DG Hernandez, MA Nalls, JD Rohrer, A Ramasamy, JBJ Kwok, ... The Lancet Neurology 13 (7), 686-699, 2014 | 413 | 2014 |
| Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial P Scheltens, JWR Twisk, R Blesa, E Scarpini, CAF von Arnim, A Bongers, ... Journal of Alzheimer's Disease 31 (1), 225-236, 2012 | 385 | 2012 |
| Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg L Querol, G Nogales-Gadea, R Rojas-Garcia, J Diaz-Manera, J Pardo, ... Neurology 82 (10), 879-886, 2014 | 379 | 2014 |
| Spanish Multicenter Normative Studies (NEURONORMA Project): norms for verbal fluency tests J Peña-Casanova, S Quinones-Ubeda, N Gramunt-Fombuena, ... Archives of Clinical Neuropsychology 24 (4), 395-411, 2009 | 331 | 2009 |
| Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, E Vilaplana, M Carmona-Iragui, B Benejam, L Videla, I Barroeta, ... The Lancet 395 (10242), 1988-1997, 2020 | 264 | 2020 |
| Reelin expression and glycosylation patterns are altered in Alzheimer’s disease A Botella-López, F Burgaya, R Gavín, MS García-Ayllón, ... Proceedings of the National Academy of Sciences 103 (14), 5573-5578, 2006 | 262 | 2006 |
| Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP RJ Guerreiro, M Baquero, R Blesa, M Boada, JM Brás, MJ Bullido, ... Neurobiology of aging 31 (5), 725-731, 2010 | 256 | 2010 |
| Spanish multicenter normative studies (NEURONORMA Project): Norms for the Rey–Osterrieth complex figure (copy and memory), and free and cued selective reminding test J Peña-Casanova, N Gramunt-Fombuena, S Quiñones-Úbeda, ... Archives of Clinical Neuropsychology 24 (4), 371-393, 2009 | 244 | 2009 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 224 | 2021 |
| Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia D Bergeron, ML Gorno‐Tempini, GD Rabinovici, MA Santos‐Santos, ... Annals of neurology 84 (5), 729-740, 2018 | 205 | 2018 |
| Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies M Colom-Cadena, E Gelpi, S Charif, O Belbin, R Blesa, MJ Martí, ... Journal of Neuropathology & Experimental Neurology 72 (12), 1203-1212, 2013 | 195 | 2013 |
| Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer's disease cerebrospinal fluid A Lleó, R Núñez-Llaves, D Alcolea, C Chiva, D Balateu-Paños, ... Molecular & Cellular Proteomics 18 (3), 546-560, 2019 | 186 | 2019 |
| Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, M Carmona-Iragui, B Benejam, S Fernández, L Videla, ... The Lancet Neurology 17 (10), 860-869, 2018 | 185 | 2018 |
| Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course N Setó‐Salvia, J Pagonabarraga, H Houlden, B Pascual‐Sedano, ... Movement Disorders 27 (3), 393-399, 2012 | 183 | 2012 |
